London man paralyzed by tornado, family asks for help
LONDON, Ky. (FOX 56) — Shawn Cupp was overcome with emotion as she looked at the dirt patch where her home on Philpot Road in London once stood. It is also where her brother, David, nearly died in Friday's tornado.
'It's amazing that he made it,' Cupp said through tears. 'He said he remembers it picking him up and it slinging him through the wall.'
London mayor warns of stolen pets after deadly tornado
EKU offers help to students impacted by deadly southern Kentucky tornado: How to receive it
London man paralyzed by tornado, family asks for help
She said David was diagnosed with spinal meningitis as a baby, which caused long-term damage to his brain.
After their mother passed, Shawn became the primary caregiver of her now 46-year-old brother.
Shawn was on her way home from work when the tornado came through, which meant that David was home alone. Fortunately, though, neighbors heard his cries for help.
'My brother was lying on his bedroom door when they found him, so they just grabbed the bedroom door and slid him out of the rubble that was down there, about 80 feet from where he started at,' she said.
David is still in the ICU, but his life will never be the same. His injuries from the storm left him paralyzed from the waist down.
'He tried to stand up, and he couldn't, so he said he knew he was paralyzed,' Cupp said.
Kentucky's most misspelled word, according to study
Drug overdoses see major decline: How Kentucky measures up
UFO sightings in Kentucky: A look back on past 30 years
When David was found, Shawn told FOX 56 that their mother's urn was lying just feet from David, almost completely intact.
'God and I believe wholeheartedly my mom was with him. There's no other explanation as to why he's still here,' she said.
Now, a GoFundMe account has been set up to help get them a new home. But not just that, one that's accessible for David, and what Shawn calls their 'new normal.'
'We just have absolutely nothing left, and they said I'm looking at a couple of months before he comes home, and I need to have him home and have everything accessible,' Cupp said. 'I want to have everything to make him as comfortable as possible, to give him the best life that I can.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Virginia honors Virginia Beach firefighter who lost his life to cancer
VIRGINIA BEACH, Va. (WAVY) — For years, firefighter Matthew Gallina was exposed to the toxins from fires, both small and large, that put him at risk for a host of rare and deadly cancers. First responders from across the region rushed to the Mayfair Mews Apartment complex in Virginia Beach on April 6, 2012, when a fighter jet slammed into the buildings. The fire was dubbed the Good Friday miracle; no one died. 'Good Friday Miracle': F-18 jet crash into Virginia Beach apartment turns 10 Since Gallina was part of the arson squad, he wasn't assigned to the scene but had to dig through the scene after the incident. 'So if there is an arson, investigation, then my Matt would go out and dig through that scene, and there's a multitude of cancer causing agents,' Gallina's wife Michelle Gallina said. Michelle also said her husband shared space with gear that was contaminated at Mayflower Mews. 'He did not go to the Good Friday plane crash,' Michelle said. 'His, the gear from the Good Friday plane crash was stored at his station, so that's, that's one part of, of the situation was, all of the turnout gear, the equipment that came back to his station for decon, but, you know, there is there's information that, the turnout gear itself, has cancer causing, material.' In June of 2023, Gallina, who had no symptoms, tested for a wide variety of cancers. The test came back positive for stage four esophageal cancer — Gallina died just 14 months later. Funeral services were held at Norfolk's Harbor Park. 10 On Your Side's Regina Mobley asked Michelle what her reaction would be if one of her three children wanted to be a firefighter. 'That's a hard question. And, I don't know,' Michelle said. 'I'm hoping that, you know, the camaraderie of the fire department is is so amazing, and it's, it brings you in. The support that I've gotten from the fire department, from the union, from friends and family, has been overwhelming. On Saturday, Virginia will honor Matt Gallina and 11 other first responders who made the ultimate sacrifice in service to the commonwealth. The event takes place at noon at the Richmond International Raceway Complex. If you can't make it to Richmond, the event will be streamed live at the link here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Hartford HealthCare and Pfizer partner to tackle workplace migraines
HARTFORD, Conn. (WTNH) — A new partnership between Hartford HealthCare and Pfizer is taking aim at migraines in the workplace. The innovative program is designed to raise awareness, improve access to care, and boost productivity for employees living with migraine. Deanna Gorman, system director of laboratory quality management at Hartford HealthCare, joined Good Morning Connecticut at 9 a.m. to discuss. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory
We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest's Substack. In this article, we will summarize the bulls' thesis on REGN. Regeneron Pharmaceuticals, Inc. (REGN)'s share was trading at $605.39 as of 29th May. REGN's trailing and forward P/E were 15.39 and 17.39 respectively according to Yahoo Finance. A scientist in a lab conducting research on cell-based therapeutics and biotechnology. Regeneron's latest earnings report was notably weak, with a 3.7% revenue decline and a 14% EPS drop, surprising given the company's history of exceeding market expectations. The primary driver was a steep 26% year-over-year decline in the U.S. Eylea franchise, particularly a 39% drop in 2mg Eylea sales. This was partly due to a co-pay assistance funding gap, which forced many Medicare patients to switch to cheaper alternatives like compounded Avastin, impacting both Regeneron and rival Roche's Vabysmo. Regeneron, having contributed over $400 million last year to charitable foundations supporting co-pay assistance, is now seeking to share this burden, proposing a matching donation program to encourage broader industry support. Another setback was the FDA's Complete Response Letter delaying approval of the Eylea-HD pre-filled syringe, a key product needed to compete with Vabysmo. The delay stemmed from third-party component issues rather than drug efficacy, and management believes resolution could be near. Margins also contracted, with gross margin falling from 89% to 85% due to unspecified inventory write-offs, possibly related to older Eylea 2mg or even leftover REGEN-COV stock. However, the margin pressure appears more tied to one-offs and increased R&D spending than structural issues. On a more positive note, Regeneron's pipeline is broadening meaningfully. Itepekimab, an IL-33 antibody, shows promise as a major respiratory asset with pivotal COPD data upcoming and expanded trials underway. The growing RNAi pipeline, now at nine siRNAs through its Alnylam collaboration, signals Regeneron's potential evolution beyond antibodies into a broader genetic medicine powerhouse. Regeneron Pharmaceuticals, Inc. (REGN) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 66 hedge fund portfolios held REGN at the end of the first quarter which was 68 in the previous quarter. While we acknowledge the potential of LYFT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Sign in to access your portfolio
